nodes	percent_of_prediction	percent_of_DWPC	metapath
Prasugrel—ALB—Estropipate—osteoporosis	0.111	0.15	CbGbCtD
Prasugrel—CYP2B6—Raloxifene—osteoporosis	0.0756	0.102	CbGbCtD
Prasugrel—CYP2B6—Ethinyl Estradiol—osteoporosis	0.0731	0.0989	CbGbCtD
Prasugrel—CYP2C9—Estropipate—osteoporosis	0.0599	0.081	CbGbCtD
Prasugrel—CYP2B6—Cholecalciferol—osteoporosis	0.0584	0.079	CbGbCtD
Prasugrel—ALB—Estradiol—osteoporosis	0.0461	0.0624	CbGbCtD
Prasugrel—CYP2C19—Cholecalciferol—osteoporosis	0.0371	0.0502	CbGbCtD
Prasugrel—CYP3A4—Calcitriol—osteoporosis	0.0348	0.0471	CbGbCtD
Prasugrel—CYP3A4—Estropipate—osteoporosis	0.0348	0.0471	CbGbCtD
Prasugrel—CYP2C9—Cholecalciferol—osteoporosis	0.0309	0.0417	CbGbCtD
Prasugrel—CYP2C19—Estradiol—osteoporosis	0.0299	0.0405	CbGbCtD
Prasugrel—CYP3A4—Ergocalciferol—osteoporosis	0.0278	0.0377	CbGbCtD
Prasugrel—CYP2C9—Estradiol—osteoporosis	0.0249	0.0337	CbGbCtD
Prasugrel—CYP3A4—Raloxifene—osteoporosis	0.0232	0.0314	CbGbCtD
Prasugrel—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0224	0.0304	CbGbCtD
Prasugrel—CYP3A4—Cholecalciferol—osteoporosis	0.0179	0.0243	CbGbCtD
Prasugrel—CYP3A4—Conjugated Estrogens—osteoporosis	0.0165	0.0223	CbGbCtD
Prasugrel—CYP3A4—Estradiol—osteoporosis	0.0145	0.0196	CbGbCtD
Prasugrel—Mediastinal disorder—Ibandronate—osteoporosis	0.000812	0.00385	CcSEcCtD
Prasugrel—Diarrhoea—Calcium Acetate—osteoporosis	0.000804	0.00382	CcSEcCtD
Prasugrel—Back pain—Estropipate—osteoporosis	0.000791	0.00375	CcSEcCtD
Prasugrel—Dizziness—Calcium Acetate—osteoporosis	0.000777	0.00369	CcSEcCtD
Prasugrel—Haemoglobin—Ethinyl Estradiol—osteoporosis	0.000766	0.00363	CcSEcCtD
Prasugrel—Haemorrhage—Ethinyl Estradiol—osteoporosis	0.000762	0.00361	CcSEcCtD
Prasugrel—Back pain—Ibandronate—osteoporosis	0.000759	0.0036	CcSEcCtD
Prasugrel—Urinary tract disorder—Ethinyl Estradiol—osteoporosis	0.000752	0.00357	CcSEcCtD
Prasugrel—Haematuria—Pamidronate—osteoporosis	0.00075	0.00356	CcSEcCtD
Prasugrel—Angioedema—Estropipate—osteoporosis	0.000747	0.00355	CcSEcCtD
Prasugrel—Urethral disorder—Ethinyl Estradiol—osteoporosis	0.000747	0.00354	CcSEcCtD
Prasugrel—Haemoglobin—Risedronate—osteoporosis	0.000746	0.00354	CcSEcCtD
Prasugrel—Asthenia—Ergocalciferol—osteoporosis	0.000745	0.00353	CcSEcCtD
Prasugrel—Anaemia—Alendronate—osteoporosis	0.000745	0.00353	CcSEcCtD
Prasugrel—Haemorrhage—Risedronate—osteoporosis	0.000743	0.00352	CcSEcCtD
Prasugrel—Angioedema—Alendronate—osteoporosis	0.000736	0.00349	CcSEcCtD
Prasugrel—Urinary tract disorder—Risedronate—osteoporosis	0.000733	0.00348	CcSEcCtD
Prasugrel—Cerebrovascular accident—Estradiol—osteoporosis	0.000733	0.00348	CcSEcCtD
Prasugrel—Oedema peripheral—Risedronate—osteoporosis	0.000732	0.00347	CcSEcCtD
Prasugrel—Urethral disorder—Risedronate—osteoporosis	0.000728	0.00345	CcSEcCtD
Prasugrel—Anaemia—Ibandronate—osteoporosis	0.000725	0.00344	CcSEcCtD
Prasugrel—Pain in extremity—Estradiol—osteoporosis	0.000718	0.00341	CcSEcCtD
Prasugrel—Angioedema—Ibandronate—osteoporosis	0.000717	0.0034	CcSEcCtD
Prasugrel—Cough—Estropipate—osteoporosis	0.000714	0.00339	CcSEcCtD
Prasugrel—Eye disorder—Ethinyl Estradiol—osteoporosis	0.000712	0.00338	CcSEcCtD
Prasugrel—Haemoglobin—Pamidronate—osteoporosis	0.00071	0.00337	CcSEcCtD
Prasugrel—Haemorrhage—Pamidronate—osteoporosis	0.000706	0.00335	CcSEcCtD
Prasugrel—Nausea—Calcium Acetate—osteoporosis	0.000698	0.00331	CcSEcCtD
Prasugrel—Urinary tract disorder—Pamidronate—osteoporosis	0.000697	0.00331	CcSEcCtD
Prasugrel—Eye disorder—Risedronate—osteoporosis	0.000694	0.00329	CcSEcCtD
Prasugrel—Urethral disorder—Pamidronate—osteoporosis	0.000692	0.00328	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Estropipate—osteoporosis	0.000692	0.00328	CcSEcCtD
Prasugrel—Cough—Raloxifene—osteoporosis	0.000691	0.00328	CcSEcCtD
Prasugrel—Angiopathy—Ethinyl Estradiol—osteoporosis	0.000691	0.00328	CcSEcCtD
Prasugrel—Immune system disorder—Ethinyl Estradiol—osteoporosis	0.000688	0.00326	CcSEcCtD
Prasugrel—Haematuria—Zoledronate—osteoporosis	0.000685	0.00325	CcSEcCtD
Prasugrel—Hypertension—Ibandronate—osteoporosis	0.000677	0.00321	CcSEcCtD
Prasugrel—Angiopathy—Risedronate—osteoporosis	0.000674	0.0032	CcSEcCtD
Prasugrel—Immune system disorder—Risedronate—osteoporosis	0.000671	0.00318	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Raloxifene—osteoporosis	0.00067	0.00318	CcSEcCtD
Prasugrel—Mediastinal disorder—Risedronate—osteoporosis	0.000669	0.00317	CcSEcCtD
Prasugrel—Anaphylactic shock—Estropipate—osteoporosis	0.000668	0.00317	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Ibandronate—osteoporosis	0.000663	0.00315	CcSEcCtD
Prasugrel—Hypertension—Calcitriol—osteoporosis	0.000663	0.00314	CcSEcCtD
Prasugrel—Eye disorder—Pamidronate—osteoporosis	0.00066	0.00313	CcSEcCtD
Prasugrel—Bradycardia—Zoledronate—osteoporosis	0.000656	0.00311	CcSEcCtD
Prasugrel—Skin disorder—Estropipate—osteoporosis	0.000648	0.00308	CcSEcCtD
Prasugrel—Back pain—Ethinyl Estradiol—osteoporosis	0.000641	0.00304	CcSEcCtD
Prasugrel—Angiopathy—Pamidronate—osteoporosis	0.00064	0.00304	CcSEcCtD
Prasugrel—Anaphylactic shock—Ibandronate—osteoporosis	0.00064	0.00304	CcSEcCtD
Prasugrel—Immune system disorder—Pamidronate—osteoporosis	0.000638	0.00302	CcSEcCtD
Prasugrel—Urinary tract disorder—Zoledronate—osteoporosis	0.000637	0.00302	CcSEcCtD
Prasugrel—Mediastinal disorder—Pamidronate—osteoporosis	0.000636	0.00302	CcSEcCtD
Prasugrel—Oedema peripheral—Zoledronate—osteoporosis	0.000635	0.00301	CcSEcCtD
Prasugrel—Thrombocytopenia—Raloxifene—osteoporosis	0.000633	0.003	CcSEcCtD
Prasugrel—Urethral disorder—Zoledronate—osteoporosis	0.000632	0.003	CcSEcCtD
Prasugrel—Skin disorder—Raloxifene—osteoporosis	0.000628	0.00298	CcSEcCtD
Prasugrel—Anaphylactic shock—Calcitriol—osteoporosis	0.000627	0.00297	CcSEcCtD
Prasugrel—Back pain—Risedronate—osteoporosis	0.000625	0.00297	CcSEcCtD
Prasugrel—Skin disorder—Ibandronate—osteoporosis	0.000622	0.00295	CcSEcCtD
Prasugrel—Nausea—Ergocalciferol—osteoporosis	0.000617	0.00293	CcSEcCtD
Prasugrel—Oedema peripheral—Conjugated Estrogens—osteoporosis	0.000612	0.0029	CcSEcCtD
Prasugrel—Skin disorder—Calcitriol—osteoporosis	0.000609	0.00289	CcSEcCtD
Prasugrel—Angioedema—Ethinyl Estradiol—osteoporosis	0.000606	0.00287	CcSEcCtD
Prasugrel—Eye disorder—Zoledronate—osteoporosis	0.000603	0.00286	CcSEcCtD
Prasugrel—Anaemia—Risedronate—osteoporosis	0.000597	0.00283	CcSEcCtD
Prasugrel—Back pain—Pamidronate—osteoporosis	0.000594	0.00282	CcSEcCtD
Prasugrel—Angioedema—Risedronate—osteoporosis	0.000591	0.0028	CcSEcCtD
Prasugrel—Angiopathy—Zoledronate—osteoporosis	0.000585	0.00278	CcSEcCtD
Prasugrel—Immune system disorder—Zoledronate—osteoporosis	0.000582	0.00276	CcSEcCtD
Prasugrel—Mediastinal disorder—Zoledronate—osteoporosis	0.000581	0.00276	CcSEcCtD
Prasugrel—Eye disorder—Conjugated Estrogens—osteoporosis	0.00058	0.00275	CcSEcCtD
Prasugrel—Cough—Ethinyl Estradiol—osteoporosis	0.000579	0.00274	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Estropipate—osteoporosis	0.000576	0.00273	CcSEcCtD
Prasugrel—Fatigue—Estropipate—osteoporosis	0.000576	0.00273	CcSEcCtD
Prasugrel—Hypersensitivity—Etidronic acid—osteoporosis	0.000569	0.0027	CcSEcCtD
Prasugrel—Anaemia—Pamidronate—osteoporosis	0.000568	0.00269	CcSEcCtD
Prasugrel—Cough—Risedronate—osteoporosis	0.000564	0.00268	CcSEcCtD
Prasugrel—Angiopathy—Conjugated Estrogens—osteoporosis	0.000563	0.00267	CcSEcCtD
Prasugrel—Angioedema—Pamidronate—osteoporosis	0.000562	0.00266	CcSEcCtD
Prasugrel—Immune system disorder—Conjugated Estrogens—osteoporosis	0.000561	0.00266	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.000561	0.00266	CcSEcCtD
Prasugrel—Mediastinal disorder—Conjugated Estrogens—osteoporosis	0.00056	0.00265	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Raloxifene—osteoporosis	0.000558	0.00265	CcSEcCtD
Prasugrel—Hypertension—Risedronate—osteoporosis	0.000558	0.00265	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Ibandronate—osteoporosis	0.000553	0.00262	CcSEcCtD
Prasugrel—Fatigue—Ibandronate—osteoporosis	0.000552	0.00262	CcSEcCtD
Prasugrel—Leukopenia—Pamidronate—osteoporosis	0.00055	0.00261	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.000547	0.00259	CcSEcCtD
Prasugrel—Back pain—Zoledronate—osteoporosis	0.000543	0.00258	CcSEcCtD
Prasugrel—Cough—Pamidronate—osteoporosis	0.000536	0.00254	CcSEcCtD
Prasugrel—Hypertension—Pamidronate—osteoporosis	0.000531	0.00252	CcSEcCtD
Prasugrel—Diarrhoea—Etidronic acid—osteoporosis	0.000528	0.0025	CcSEcCtD
Prasugrel—Haematuria—Estradiol—osteoporosis	0.000528	0.0025	CcSEcCtD
Prasugrel—Body temperature increased—Estropipate—osteoporosis	0.000528	0.0025	CcSEcCtD
Prasugrel—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000526	0.00249	CcSEcCtD
Prasugrel—Back pain—Conjugated Estrogens—osteoporosis	0.000523	0.00248	CcSEcCtD
Prasugrel—Epistaxis—Estradiol—osteoporosis	0.000522	0.00248	CcSEcCtD
Prasugrel—Body temperature increased—Alendronate—osteoporosis	0.00052	0.00247	CcSEcCtD
Prasugrel—Anaemia—Zoledronate—osteoporosis	0.000519	0.00246	CcSEcCtD
Prasugrel—Angioedema—Zoledronate—osteoporosis	0.000513	0.00243	CcSEcCtD
Prasugrel—Skin disorder—Risedronate—osteoporosis	0.000512	0.00243	CcSEcCtD
Prasugrel—Body temperature increased—Raloxifene—osteoporosis	0.000511	0.00242	CcSEcCtD
Prasugrel—Body temperature increased—Ibandronate—osteoporosis	0.000506	0.0024	CcSEcCtD
Prasugrel—Leukopenia—Zoledronate—osteoporosis	0.000502	0.00238	CcSEcCtD
Prasugrel—Anaphylactic shock—Pamidronate—osteoporosis	0.000502	0.00238	CcSEcCtD
Prasugrel—Haemoglobin—Estradiol—osteoporosis	0.000499	0.00237	CcSEcCtD
Prasugrel—Haemorrhage—Estradiol—osteoporosis	0.000497	0.00236	CcSEcCtD
Prasugrel—Body temperature increased—Calcitriol—osteoporosis	0.000495	0.00235	CcSEcCtD
Prasugrel—Angioedema—Conjugated Estrogens—osteoporosis	0.000494	0.00234	CcSEcCtD
Prasugrel—Hypersensitivity—Estropipate—osteoporosis	0.000492	0.00233	CcSEcCtD
Prasugrel—Thrombocytopenia—Pamidronate—osteoporosis	0.000491	0.00233	CcSEcCtD
Prasugrel—Urinary tract disorder—Estradiol—osteoporosis	0.000491	0.00233	CcSEcCtD
Prasugrel—Cough—Zoledronate—osteoporosis	0.00049	0.00232	CcSEcCtD
Prasugrel—Oedema peripheral—Estradiol—osteoporosis	0.00049	0.00232	CcSEcCtD
Prasugrel—Urethral disorder—Estradiol—osteoporosis	0.000487	0.00231	CcSEcCtD
Prasugrel—Rash—Etidronic acid—osteoporosis	0.000487	0.00231	CcSEcCtD
Prasugrel—Dermatitis—Etidronic acid—osteoporosis	0.000486	0.00231	CcSEcCtD
Prasugrel—Hypertension—Zoledronate—osteoporosis	0.000485	0.0023	CcSEcCtD
Prasugrel—Hypersensitivity—Alendronate—osteoporosis	0.000484	0.0023	CcSEcCtD
Prasugrel—Headache—Etidronic acid—osteoporosis	0.000483	0.00229	CcSEcCtD
Prasugrel—Asthenia—Estropipate—osteoporosis	0.000479	0.00227	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000475	0.00225	CcSEcCtD
Prasugrel—Asthenia—Alendronate—osteoporosis	0.000472	0.00224	CcSEcCtD
Prasugrel—Hypersensitivity—Ibandronate—osteoporosis	0.000472	0.00224	CcSEcCtD
Prasugrel—Cough—Conjugated Estrogens—osteoporosis	0.000472	0.00224	CcSEcCtD
Prasugrel—Dyspnoea—Risedronate—osteoporosis	0.00047	0.00223	CcSEcCtD
Prasugrel—Hypotension—Pamidronate—osteoporosis	0.000469	0.00222	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000467	0.00222	CcSEcCtD
Prasugrel—Fatigue—Ethinyl Estradiol—osteoporosis	0.000467	0.00221	CcSEcCtD
Prasugrel—Eye disorder—Estradiol—osteoporosis	0.000464	0.0022	CcSEcCtD
Prasugrel—Hypersensitivity—Calcitriol—osteoporosis	0.000462	0.00219	CcSEcCtD
Prasugrel—Asthenia—Ibandronate—osteoporosis	0.000459	0.00218	CcSEcCtD
Prasugrel—Nausea—Etidronic acid—osteoporosis	0.000458	0.00217	CcSEcCtD
Prasugrel—Anaphylactic shock—Zoledronate—osteoporosis	0.000458	0.00217	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000457	0.00217	CcSEcCtD
Prasugrel—Diarrhoea—Estropipate—osteoporosis	0.000457	0.00217	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Risedronate—osteoporosis	0.000455	0.00216	CcSEcCtD
Prasugrel—Fatigue—Risedronate—osteoporosis	0.000455	0.00216	CcSEcCtD
Prasugrel—Angiopathy—Estradiol—osteoporosis	0.000451	0.00214	CcSEcCtD
Prasugrel—Diarrhoea—Alendronate—osteoporosis	0.00045	0.00213	CcSEcCtD
Prasugrel—Asthenia—Calcitriol—osteoporosis	0.00045	0.00213	CcSEcCtD
Prasugrel—Immune system disorder—Estradiol—osteoporosis	0.000449	0.00213	CcSEcCtD
Prasugrel—Thrombocytopenia—Zoledronate—osteoporosis	0.000449	0.00213	CcSEcCtD
Prasugrel—Mediastinal disorder—Estradiol—osteoporosis	0.000448	0.00212	CcSEcCtD
Prasugrel—Dyspnoea—Pamidronate—osteoporosis	0.000447	0.00212	CcSEcCtD
Prasugrel—Skin disorder—Zoledronate—osteoporosis	0.000445	0.00211	CcSEcCtD
Prasugrel—Diarrhoea—Raloxifene—osteoporosis	0.000442	0.0021	CcSEcCtD
Prasugrel—Dizziness—Estropipate—osteoporosis	0.000441	0.00209	CcSEcCtD
Prasugrel—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000441	0.00209	CcSEcCtD
Prasugrel—Diarrhoea—Ibandronate—osteoporosis	0.000438	0.00208	CcSEcCtD
Prasugrel—Dizziness—Alendronate—osteoporosis	0.000435	0.00206	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000433	0.00205	CcSEcCtD
Prasugrel—Fatigue—Pamidronate—osteoporosis	0.000432	0.00205	CcSEcCtD
Prasugrel—Diarrhoea—Calcitriol—osteoporosis	0.000429	0.00203	CcSEcCtD
Prasugrel—Skin disorder—Conjugated Estrogens—osteoporosis	0.000428	0.00203	CcSEcCtD
Prasugrel—Hypotension—Zoledronate—osteoporosis	0.000428	0.00203	CcSEcCtD
Prasugrel—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000428	0.00203	CcSEcCtD
Prasugrel—Dizziness—Raloxifene—osteoporosis	0.000428	0.00203	CcSEcCtD
Prasugrel—Dizziness—Ibandronate—osteoporosis	0.000423	0.00201	CcSEcCtD
Prasugrel—Rash—Estropipate—osteoporosis	0.000421	0.002	CcSEcCtD
Prasugrel—Dermatitis—Estropipate—osteoporosis	0.000421	0.00199	CcSEcCtD
Prasugrel—Back pain—Estradiol—osteoporosis	0.000418	0.00198	CcSEcCtD
Prasugrel—Headache—Estropipate—osteoporosis	0.000418	0.00198	CcSEcCtD
Prasugrel—Body temperature increased—Risedronate—osteoporosis	0.000417	0.00198	CcSEcCtD
Prasugrel—Rash—Alendronate—osteoporosis	0.000415	0.00197	CcSEcCtD
Prasugrel—Dermatitis—Alendronate—osteoporosis	0.000414	0.00196	CcSEcCtD
Prasugrel—Hypotension—Conjugated Estrogens—osteoporosis	0.000412	0.00196	CcSEcCtD
Prasugrel—Headache—Alendronate—osteoporosis	0.000412	0.00195	CcSEcCtD
Prasugrel—Dyspnoea—Zoledronate—osteoporosis	0.000408	0.00194	CcSEcCtD
Prasugrel—Rash—Raloxifene—osteoporosis	0.000408	0.00193	CcSEcCtD
Prasugrel—Dermatitis—Raloxifene—osteoporosis	0.000407	0.00193	CcSEcCtD
Prasugrel—Headache—Raloxifene—osteoporosis	0.000405	0.00192	CcSEcCtD
Prasugrel—Rash—Ibandronate—osteoporosis	0.000404	0.00191	CcSEcCtD
Prasugrel—Dermatitis—Ibandronate—osteoporosis	0.000403	0.00191	CcSEcCtD
Prasugrel—Headache—Ibandronate—osteoporosis	0.000401	0.0019	CcSEcCtD
Prasugrel—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000399	0.00189	CcSEcCtD
Prasugrel—Nausea—Estropipate—osteoporosis	0.000397	0.00188	CcSEcCtD
Prasugrel—Body temperature increased—Pamidronate—osteoporosis	0.000396	0.00188	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000396	0.00188	CcSEcCtD
Prasugrel—Angioedema—Estradiol—osteoporosis	0.000395	0.00187	CcSEcCtD
Prasugrel—Rash—Calcitriol—osteoporosis	0.000395	0.00187	CcSEcCtD
Prasugrel—Fatigue—Zoledronate—osteoporosis	0.000395	0.00187	CcSEcCtD
Prasugrel—Dermatitis—Calcitriol—osteoporosis	0.000395	0.00187	CcSEcCtD
Prasugrel—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000393	0.00187	CcSEcCtD
Prasugrel—Headache—Calcitriol—osteoporosis	0.000393	0.00186	CcSEcCtD
Prasugrel—Nausea—Alendronate—osteoporosis	0.000391	0.00185	CcSEcCtD
Prasugrel—Hypersensitivity—Risedronate—osteoporosis	0.000389	0.00184	CcSEcCtD
Prasugrel—Asthenia—Ethinyl Estradiol—osteoporosis	0.000388	0.00184	CcSEcCtD
Prasugrel—Nausea—Raloxifene—osteoporosis	0.000384	0.00182	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000381	0.00181	CcSEcCtD
Prasugrel—Fatigue—Conjugated Estrogens—osteoporosis	0.00038	0.0018	CcSEcCtD
Prasugrel—Nausea—Ibandronate—osteoporosis	0.00038	0.0018	CcSEcCtD
Prasugrel—Asthenia—Risedronate—osteoporosis	0.000379	0.0018	CcSEcCtD
Prasugrel—Cough—Estradiol—osteoporosis	0.000377	0.00179	CcSEcCtD
Prasugrel—Hypertension—Estradiol—osteoporosis	0.000373	0.00177	CcSEcCtD
Prasugrel—Nausea—Calcitriol—osteoporosis	0.000372	0.00177	CcSEcCtD
Prasugrel—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.00037	0.00176	CcSEcCtD
Prasugrel—Hypersensitivity—Pamidronate—osteoporosis	0.00037	0.00175	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000366	0.00173	CcSEcCtD
Prasugrel—Body temperature increased—Zoledronate—osteoporosis	0.000362	0.00172	CcSEcCtD
Prasugrel—Diarrhoea—Risedronate—osteoporosis	0.000361	0.00171	CcSEcCtD
Prasugrel—Asthenia—Pamidronate—osteoporosis	0.00036	0.00171	CcSEcCtD
Prasugrel—Dizziness—Ethinyl Estradiol—osteoporosis	0.000358	0.0017	CcSEcCtD
Prasugrel—Anaphylactic shock—Estradiol—osteoporosis	0.000353	0.00167	CcSEcCtD
Prasugrel—Dizziness—Risedronate—osteoporosis	0.000349	0.00165	CcSEcCtD
Prasugrel—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000349	0.00165	CcSEcCtD
Prasugrel—Diarrhoea—Pamidronate—osteoporosis	0.000343	0.00163	CcSEcCtD
Prasugrel—Skin disorder—Estradiol—osteoporosis	0.000343	0.00163	CcSEcCtD
Prasugrel—Rash—Ethinyl Estradiol—osteoporosis	0.000341	0.00162	CcSEcCtD
Prasugrel—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000341	0.00162	CcSEcCtD
Prasugrel—Headache—Ethinyl Estradiol—osteoporosis	0.000339	0.00161	CcSEcCtD
Prasugrel—Hypersensitivity—Zoledronate—osteoporosis	0.000338	0.0016	CcSEcCtD
Prasugrel—Rash—Risedronate—osteoporosis	0.000333	0.00158	CcSEcCtD
Prasugrel—Dermatitis—Risedronate—osteoporosis	0.000332	0.00158	CcSEcCtD
Prasugrel—Dizziness—Pamidronate—osteoporosis	0.000332	0.00157	CcSEcCtD
Prasugrel—Headache—Risedronate—osteoporosis	0.000331	0.00157	CcSEcCtD
Prasugrel—Asthenia—Zoledronate—osteoporosis	0.000329	0.00156	CcSEcCtD
Prasugrel—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000325	0.00154	CcSEcCtD
Prasugrel—Nausea—Ethinyl Estradiol—osteoporosis	0.000321	0.00152	CcSEcCtD
Prasugrel—Asthenia—Conjugated Estrogens—osteoporosis	0.000316	0.0015	CcSEcCtD
Prasugrel—Rash—Pamidronate—osteoporosis	0.000316	0.0015	CcSEcCtD
Prasugrel—Dermatitis—Pamidronate—osteoporosis	0.000316	0.0015	CcSEcCtD
Prasugrel—Dyspnoea—Estradiol—osteoporosis	0.000315	0.00149	CcSEcCtD
Prasugrel—Headache—Pamidronate—osteoporosis	0.000314	0.00149	CcSEcCtD
Prasugrel—Diarrhoea—Zoledronate—osteoporosis	0.000313	0.00149	CcSEcCtD
Prasugrel—Nausea—Risedronate—osteoporosis	0.000313	0.00149	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Estradiol—osteoporosis	0.000305	0.00145	CcSEcCtD
Prasugrel—Fatigue—Estradiol—osteoporosis	0.000304	0.00144	CcSEcCtD
Prasugrel—Dizziness—Zoledronate—osteoporosis	0.000303	0.00144	CcSEcCtD
Prasugrel—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000302	0.00143	CcSEcCtD
Prasugrel—Nausea—Pamidronate—osteoporosis	0.000298	0.00141	CcSEcCtD
Prasugrel—Dizziness—Conjugated Estrogens—osteoporosis	0.000292	0.00138	CcSEcCtD
Prasugrel—Rash—Zoledronate—osteoporosis	0.000289	0.00137	CcSEcCtD
Prasugrel—Dermatitis—Zoledronate—osteoporosis	0.000289	0.00137	CcSEcCtD
Prasugrel—Headache—Zoledronate—osteoporosis	0.000287	0.00136	CcSEcCtD
Prasugrel—Body temperature increased—Estradiol—osteoporosis	0.000279	0.00132	CcSEcCtD
Prasugrel—Rash—Conjugated Estrogens—osteoporosis	0.000278	0.00132	CcSEcCtD
Prasugrel—Dermatitis—Conjugated Estrogens—osteoporosis	0.000278	0.00132	CcSEcCtD
Prasugrel—Headache—Conjugated Estrogens—osteoporosis	0.000276	0.00131	CcSEcCtD
Prasugrel—Nausea—Zoledronate—osteoporosis	0.000272	0.00129	CcSEcCtD
Prasugrel—Nausea—Conjugated Estrogens—osteoporosis	0.000262	0.00124	CcSEcCtD
Prasugrel—Hypersensitivity—Estradiol—osteoporosis	0.00026	0.00123	CcSEcCtD
Prasugrel—Asthenia—Estradiol—osteoporosis	0.000253	0.0012	CcSEcCtD
Prasugrel—Diarrhoea—Estradiol—osteoporosis	0.000242	0.00115	CcSEcCtD
Prasugrel—Dizziness—Estradiol—osteoporosis	0.000233	0.00111	CcSEcCtD
Prasugrel—Rash—Estradiol—osteoporosis	0.000223	0.00106	CcSEcCtD
Prasugrel—Dermatitis—Estradiol—osteoporosis	0.000222	0.00105	CcSEcCtD
Prasugrel—Headache—Estradiol—osteoporosis	0.000221	0.00105	CcSEcCtD
Prasugrel—Nausea—Estradiol—osteoporosis	0.00021	0.000995	CcSEcCtD
Prasugrel—P2RY12—Signaling by GPCR—WNT1—osteoporosis	0.000123	0.00245	CbGpPWpGaD
Prasugrel—P2RY12—GPCR downstream signaling—PTHLH—osteoporosis	0.000123	0.00244	CbGpPWpGaD
Prasugrel—ALB—Selenium Micronutrient Network—GPX1—osteoporosis	0.000122	0.00243	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—MGLL—osteoporosis	0.00012	0.00239	CbGpPWpGaD
Prasugrel—CYP2B6—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000118	0.00234	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—LRP5—osteoporosis	0.000117	0.00233	CbGpPWpGaD
Prasugrel—ALB—Selenium Micronutrient Network—MTHFR—osteoporosis	0.000112	0.00224	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—LRP6—osteoporosis	0.000112	0.00223	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000111	0.00222	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—PTHLH—osteoporosis	0.000111	0.00222	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—RAP1A—osteoporosis	0.000111	0.00221	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—CAP1—osteoporosis	0.000111	0.0022	CbGpPWpGaD
Prasugrel—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.00011	0.00219	CbGpPWpGaD
Prasugrel—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.00011	0.00218	CbGpPWpGaD
Prasugrel—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000108	0.00216	CbGpPWpGaD
Prasugrel—P2RY12—GPCR downstream signaling—CALCA—osteoporosis	0.000108	0.00215	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000106	0.0021	CbGpPWpGaD
Prasugrel—CYP2B6—Biological oxidations—CYP19A1—osteoporosis	0.000104	0.00207	CbGpPWpGaD
Prasugrel—ALB—Vitamin B12 Metabolism—IL1B—osteoporosis	0.000103	0.00206	CbGpPWpGaD
Prasugrel—CYP2B6—Metapathway biotransformation—CYP19A1—osteoporosis	0.000103	0.00204	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—FGA—osteoporosis	0.0001	0.002	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.0001	0.00199	CbGpPWpGaD
Prasugrel—P2RY12—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	0.0001	0.00199	CbGpPWpGaD
Prasugrel—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	9.99e-05	0.00199	CbGpPWpGaD
Prasugrel—P2RY12—GPCR ligand binding—POMC—osteoporosis	9.99e-05	0.00199	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—CALCA—osteoporosis	9.8e-05	0.00195	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	9.48e-05	0.00189	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—TLN1—osteoporosis	9.46e-05	0.00189	CbGpPWpGaD
Prasugrel—ALB—Platelet degranulation—IGF1—osteoporosis	9.33e-05	0.00186	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—FGB—osteoporosis	9.14e-05	0.00182	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	9.11e-05	0.00182	CbGpPWpGaD
Prasugrel—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	8.99e-05	0.00179	CbGpPWpGaD
Prasugrel—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	8.89e-05	0.00177	CbGpPWpGaD
Prasugrel—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—osteoporosis	8.89e-05	0.00177	CbGpPWpGaD
Prasugrel—CYP2C19—Phase 1 - Functionalization of compounds—POMC—osteoporosis	8.89e-05	0.00177	CbGpPWpGaD
Prasugrel—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	8.87e-05	0.00177	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—MGLL—osteoporosis	8.79e-05	0.00175	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	8.64e-05	0.00172	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—IGF1—osteoporosis	8.59e-05	0.00171	CbGpPWpGaD
Prasugrel—ALB—Folate Metabolism—IL1B—osteoporosis	8.4e-05	0.00167	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	8.21e-05	0.00164	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—P4HB—osteoporosis	8.16e-05	0.00163	CbGpPWpGaD
Prasugrel—CYP2C9—Phase 1 - Functionalization of compounds—POMC—osteoporosis	8.1e-05	0.00161	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—ANXA2—osteoporosis	8.04e-05	0.0016	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—PLEK—osteoporosis	8.04e-05	0.0016	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	8e-05	0.00159	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—PTH—osteoporosis	7.94e-05	0.00158	CbGpPWpGaD
Prasugrel—CYP2C19—Biological oxidations—CYP19A1—osteoporosis	7.85e-05	0.00156	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—RAP1A—osteoporosis	7.8e-05	0.00155	CbGpPWpGaD
Prasugrel—CYP2C19—Metapathway biotransformation—CYP19A1—osteoporosis	7.75e-05	0.00154	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CNR2—osteoporosis	7.73e-05	0.00154	CbGpPWpGaD
Prasugrel—P2RY12—GPCR downstream signaling—ADCY5—osteoporosis	7.68e-05	0.00153	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—NFATC1—osteoporosis	7.61e-05	0.00152	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—DKK1—osteoporosis	7.55e-05	0.0015	CbGpPWpGaD
Prasugrel—ALB—Vitamin B12 Metabolism—TNF—osteoporosis	7.49e-05	0.00149	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	7.37e-05	0.00147	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—WNT1—osteoporosis	7.27e-05	0.00145	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	7.18e-05	0.00143	CbGpPWpGaD
Prasugrel—CYP2C9—Biological oxidations—CYP19A1—osteoporosis	7.16e-05	0.00143	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—FGA—osteoporosis	7.07e-05	0.00141	CbGpPWpGaD
Prasugrel—CYP2C9—Metapathway biotransformation—CYP19A1—osteoporosis	7.06e-05	0.00141	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—ADCY5—osteoporosis	6.97e-05	0.00139	CbGpPWpGaD
Prasugrel—ALB—Transmembrane transport of small molecules—ANXA2—osteoporosis	6.96e-05	0.00139	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—TLN1—osteoporosis	6.93e-05	0.00138	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—VCL—osteoporosis	6.83e-05	0.00136	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	6.72e-05	0.00134	CbGpPWpGaD
Prasugrel—ALB—Selenium Micronutrient Network—IL1B—osteoporosis	6.67e-05	0.00133	CbGpPWpGaD
Prasugrel—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	6.59e-05	0.00131	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—PTHLH—osteoporosis	6.58e-05	0.00131	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—BMP2—osteoporosis	6.58e-05	0.00131	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	6.55e-05	0.0013	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—FGB—osteoporosis	6.44e-05	0.00128	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	6.4e-05	0.00127	CbGpPWpGaD
Prasugrel—CYP2B6—Biological oxidations—POMC—osteoporosis	6.25e-05	0.00124	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—PSMA5—osteoporosis	6.21e-05	0.00124	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—PSMA2—osteoporosis	6.21e-05	0.00124	CbGpPWpGaD
Prasugrel—ALB—Folate Metabolism—TNF—osteoporosis	6.09e-05	0.00121	CbGpPWpGaD
Prasugrel—ALB—Vitamin B12 Metabolism—IL6—osteoporosis	6.04e-05	0.0012	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PKM—osteoporosis	5.89e-05	0.00117	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—FDPS—osteoporosis	5.89e-05	0.00117	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CALCA—osteoporosis	5.79e-05	0.00115	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	5.74e-05	0.00114	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—RAP1A—osteoporosis	5.71e-05	0.00114	CbGpPWpGaD
Prasugrel—P2RY12—GPCR downstream signaling—POMC—osteoporosis	5.65e-05	0.00113	CbGpPWpGaD
Prasugrel—ALB—Platelet degranulation—TGFB1—osteoporosis	5.59e-05	0.00111	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PGLS—osteoporosis	5.58e-05	0.00111	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—GPD2—osteoporosis	5.58e-05	0.00111	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	5.44e-05	0.00108	CbGpPWpGaD
Prasugrel—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	5.34e-05	0.00106	CbGpPWpGaD
Prasugrel—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoporosis	5.33e-05	0.00106	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—KL—osteoporosis	5.26e-05	0.00105	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	5.23e-05	0.00104	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—FGA—osteoporosis	5.18e-05	0.00103	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—TGFB1—osteoporosis	5.15e-05	0.00103	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—POMC—osteoporosis	5.13e-05	0.00102	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—ATIC—osteoporosis	5.11e-05	0.00102	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PNP—osteoporosis	5.11e-05	0.00102	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—IL6R—osteoporosis	5e-05	0.000997	CbGpPWpGaD
Prasugrel—ALB—Metabolism—FDPS—osteoporosis	4.96e-05	0.000988	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PKM—osteoporosis	4.96e-05	0.000988	CbGpPWpGaD
Prasugrel—ALB—Folate Metabolism—IL6—osteoporosis	4.92e-05	0.00098	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	4.88e-05	0.000973	CbGpPWpGaD
Prasugrel—ALB—Selenium Micronutrient Network—TNF—osteoporosis	4.84e-05	0.000964	CbGpPWpGaD
Prasugrel—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	4.72e-05	0.000941	CbGpPWpGaD
Prasugrel—CYP2C19—Biological oxidations—POMC—osteoporosis	4.72e-05	0.000941	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—FGB—osteoporosis	4.71e-05	0.000939	CbGpPWpGaD
Prasugrel—ALB—Metabolism—GPD2—osteoporosis	4.7e-05	0.000937	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PGLS—osteoporosis	4.7e-05	0.000937	CbGpPWpGaD
Prasugrel—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	4.66e-05	0.000928	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—FDPS—osteoporosis	4.45e-05	0.000887	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PKM—osteoporosis	4.45e-05	0.000887	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	4.45e-05	0.000887	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—OXCT1—osteoporosis	4.34e-05	0.000865	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—CA2—osteoporosis	4.34e-05	0.000865	CbGpPWpGaD
Prasugrel—CYP2C9—Biological oxidations—POMC—osteoporosis	4.3e-05	0.000858	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PNP—osteoporosis	4.3e-05	0.000857	CbGpPWpGaD
Prasugrel—ALB—Metabolism—ATIC—osteoporosis	4.3e-05	0.000857	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—MGLL—osteoporosis	4.23e-05	0.000843	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—GPD2—osteoporosis	4.22e-05	0.000841	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PGLS—osteoporosis	4.22e-05	0.000841	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—IGF1—osteoporosis	4.14e-05	0.000825	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—ADCY5—osteoporosis	4.12e-05	0.000821	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PKM—osteoporosis	4.06e-05	0.000809	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—FDPS—osteoporosis	4.06e-05	0.000809	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—SPP1—osteoporosis	3.98e-05	0.000794	CbGpPWpGaD
Prasugrel—ALB—Selenium Micronutrient Network—IL6—osteoporosis	3.91e-05	0.000778	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PNP—osteoporosis	3.86e-05	0.000769	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—ATIC—osteoporosis	3.86e-05	0.000769	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PGLS—osteoporosis	3.85e-05	0.000767	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GPD2—osteoporosis	3.85e-05	0.000767	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CA2—osteoporosis	3.66e-05	0.000728	CbGpPWpGaD
Prasugrel—ALB—Metabolism—OXCT1—osteoporosis	3.66e-05	0.000728	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—IRS2—osteoporosis	3.6e-05	0.000718	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—IDH2—osteoporosis	3.6e-05	0.000717	CbGpPWpGaD
Prasugrel—ALB—Metabolism—MGLL—osteoporosis	3.56e-05	0.00071	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—LEP—osteoporosis	3.53e-05	0.000703	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—ATIC—osteoporosis	3.52e-05	0.000701	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PNP—osteoporosis	3.52e-05	0.000701	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—CYP27A1—osteoporosis	3.38e-05	0.000674	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—ESR1—osteoporosis	3.37e-05	0.000671	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	3.36e-05	0.000669	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—ACP5—osteoporosis	3.29e-05	0.000656	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CA2—osteoporosis	3.28e-05	0.000654	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—OXCT1—osteoporosis	3.28e-05	0.000654	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—MGLL—osteoporosis	3.2e-05	0.000637	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—IRS1—osteoporosis	3.15e-05	0.000627	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—TPI1—osteoporosis	3.06e-05	0.00061	CbGpPWpGaD
Prasugrel—ALB—Metabolism—IDH2—osteoporosis	3.03e-05	0.000604	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—POMC—osteoporosis	3.03e-05	0.000604	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	3.02e-05	0.000601	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CA2—osteoporosis	2.99e-05	0.000596	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—OXCT1—osteoporosis	2.99e-05	0.000596	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—IL6R—osteoporosis	2.95e-05	0.000589	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—MGLL—osteoporosis	2.92e-05	0.000581	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—IGF1—osteoporosis	2.91e-05	0.000581	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—P4HB—osteoporosis	2.88e-05	0.000573	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CYP27A1—osteoporosis	2.85e-05	0.000568	CbGpPWpGaD
Prasugrel—CYP3A4—Biological oxidations—POMC—osteoporosis	2.84e-05	0.000566	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—GAPDH—osteoporosis	2.82e-05	0.000563	CbGpPWpGaD
Prasugrel—ALB—Metabolism—ACP5—osteoporosis	2.77e-05	0.000552	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—RAP1A—osteoporosis	2.75e-05	0.000548	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.75e-05	0.000548	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.74e-05	0.000545	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—IDH2—osteoporosis	2.72e-05	0.000542	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—FDPS—osteoporosis	2.68e-05	0.000533	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PKM—osteoporosis	2.68e-05	0.000533	CbGpPWpGaD
Prasugrel—ALB—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.61e-05	0.00052	CbGpPWpGaD
Prasugrel—ALB—Metabolism—TPI1—osteoporosis	2.58e-05	0.000513	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CYP27A1—osteoporosis	2.56e-05	0.000509	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PGLS—osteoporosis	2.54e-05	0.000506	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GPD2—osteoporosis	2.54e-05	0.000506	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—ACP5—osteoporosis	2.49e-05	0.000496	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	2.48e-05	0.000494	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—IDH2—osteoporosis	2.48e-05	0.000494	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.46e-05	0.000489	CbGpPWpGaD
Prasugrel—ALB—Metabolism—P4HB—osteoporosis	2.42e-05	0.000483	CbGpPWpGaD
Prasugrel—ALB—Metabolism—GAPDH—osteoporosis	2.38e-05	0.000474	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CYP27A1—osteoporosis	2.33e-05	0.000465	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ATIC—osteoporosis	2.32e-05	0.000463	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PNP—osteoporosis	2.32e-05	0.000463	CbGpPWpGaD
Prasugrel—ALB—Metabolism—RAP1A—osteoporosis	2.32e-05	0.000461	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—TPI1—osteoporosis	2.31e-05	0.000461	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—ACP5—osteoporosis	2.27e-05	0.000452	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.24e-05	0.000446	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—IL6—osteoporosis	2.23e-05	0.000444	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—ENO1—osteoporosis	2.22e-05	0.000443	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PSMA2—osteoporosis	2.19e-05	0.000437	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PSMA5—osteoporosis	2.19e-05	0.000437	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—P4HB—osteoporosis	2.17e-05	0.000433	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—GAPDH—osteoporosis	2.13e-05	0.000425	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—IGF1—osteoporosis	2.13e-05	0.000425	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—TPI1—osteoporosis	2.11e-05	0.00042	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—RAP1A—osteoporosis	2.08e-05	0.000414	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.02e-05	0.000402	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—P4HB—osteoporosis	1.98e-05	0.000395	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CA2—osteoporosis	1.97e-05	0.000393	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—OXCT1—osteoporosis	1.97e-05	0.000393	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GAPDH—osteoporosis	1.95e-05	0.000388	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—MGLL—osteoporosis	1.92e-05	0.000383	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—RAP1A—osteoporosis	1.9e-05	0.000378	CbGpPWpGaD
Prasugrel—ALB—Metabolism—ENO1—osteoporosis	1.87e-05	0.000373	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PSMA5—osteoporosis	1.84e-05	0.000367	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PSMA2—osteoporosis	1.84e-05	0.000367	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.81e-05	0.000361	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—CYP19A1—osteoporosis	1.78e-05	0.000354	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—MYC—osteoporosis	1.75e-05	0.000349	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—TGFB1—osteoporosis	1.75e-05	0.000348	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—ENO1—osteoporosis	1.68e-05	0.000335	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PSMA2—osteoporosis	1.66e-05	0.00033	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PSMA5—osteoporosis	1.66e-05	0.00033	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.65e-05	0.000329	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—IDH2—osteoporosis	1.64e-05	0.000326	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.54e-05	0.000306	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—ENO1—osteoporosis	1.53e-05	0.000305	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PSMA5—osteoporosis	1.51e-05	0.000301	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PSMA2—osteoporosis	1.51e-05	0.000301	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CYP19A1—osteoporosis	1.5e-05	0.000298	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ACP5—osteoporosis	1.5e-05	0.000298	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—ADCY5—osteoporosis	1.45e-05	0.000289	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—GPX1—osteoporosis	1.45e-05	0.000288	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—TPI1—osteoporosis	1.39e-05	0.000277	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CYP19A1—osteoporosis	1.34e-05	0.000268	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—MTHFR—osteoporosis	1.34e-05	0.000266	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—IL6—osteoporosis	1.32e-05	0.000262	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—P4HB—osteoporosis	1.31e-05	0.000261	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GAPDH—osteoporosis	1.28e-05	0.000256	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—TGFB1—osteoporosis	1.28e-05	0.000255	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—RAP1A—osteoporosis	1.25e-05	0.000249	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CYP19A1—osteoporosis	1.22e-05	0.000244	CbGpPWpGaD
Prasugrel—ALB—Metabolism—ADCY5—osteoporosis	1.22e-05	0.000244	CbGpPWpGaD
Prasugrel—ALB—Metabolism—GPX1—osteoporosis	1.22e-05	0.000243	CbGpPWpGaD
Prasugrel—ALB—Metabolism—MTHFR—osteoporosis	1.12e-05	0.000224	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—ADCY5—osteoporosis	1.1e-05	0.000219	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—GPX1—osteoporosis	1.09e-05	0.000218	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—POMC—osteoporosis	1.07e-05	0.000213	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ENO1—osteoporosis	1.01e-05	0.000201	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—MTHFR—osteoporosis	1.01e-05	0.000201	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—ADCY5—osteoporosis	1e-05	0.000199	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GPX1—osteoporosis	9.97e-06	0.000199	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PSMA2—osteoporosis	9.96e-06	0.000198	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PSMA5—osteoporosis	9.96e-06	0.000198	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—MTHFR—osteoporosis	9.2e-06	0.000183	CbGpPWpGaD
Prasugrel—ALB—Metabolism—POMC—osteoporosis	8.99e-06	0.000179	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CYP19A1—osteoporosis	8.08e-06	0.000161	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—POMC—osteoporosis	8.07e-06	0.000161	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—POMC—osteoporosis	7.36e-06	0.000147	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ADCY5—osteoporosis	6.6e-06	0.000131	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GPX1—osteoporosis	6.58e-06	0.000131	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—MTHFR—osteoporosis	6.07e-06	0.000121	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—POMC—osteoporosis	4.85e-06	9.67e-05	CbGpPWpGaD
